You have 9 free searches left this month | for more free features.

City

Seoul (2)

Seongnam (1)

Condition

Erosive Gastroesophageal Reflux Disease (1)

Healthy (1)

Non-erosive Gastroesphageal Reflux Disease (1)

Overall Status

Unknown status (2)

Completed (1)

Sign in for free

Phase

phase 3 (2)

phase 1 (1)

Sponsor

Hanmi Pharmaceutical Company Limited (3)

Collaborator

Intervention

hip1601 (3)

hgp1705 (2)

hgp1705 placebo (1)

hgp1805 (1)

hip1601 placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

hip1601

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Erosive Gastroesophageal Reflux Disease Trial in Seoul (HIP1601, HGP1705, HIP1601 Placebo)

Completed

Erosive Gastroesophageal Reflux Disease

HIP1601
+3 more

Seoul, Korea, Republic of

Asan Medical Center

Nov 26, 2020

Non-erosive Gastroesphageal Reflux Disease Trial in Seongnam (HIP1601, HGP1805)

Unknown status

Non-erosive Gastroesphageal Reflux Disease

HIP1601
HGP1805

Seongnam, Gyeonggi-do, Korea, Republic of

Seoul National University Bundang Hospital

Apr 13, 2020

Healthy Trial in Seoul (HIP1601, HGP1705)

Unknown status

Healthy

HIP1601
HGP1705

Seoul, Korea, Republic of

Seoul National University Hospital

Jan 14, 2018